FDA approves Afrezza
On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve glycemic control…
Web Exclusives
Bullying toolkit available
Access “Civility Tool-kit: Resources to Empower Nurse Leaders to Identify, Intervene, and Prevent Workplace Bullying,” supported by the RWJF Executive Nurse Fellows Program, funded…
Study: Fecal microbiota transplant effective in immunocompromised patients
Fecal microbiota transplant (FMT) for the treatment of Clostridium difficile infection in immunocompromised patients is safe and effective, according to a study in the…
Lessons for more efficient research in healthcare settings
My Own Health Report, a collaboration between seven research institutions with the goal of streamlining how healthcare providers communicate with patients about preventative health…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma, a rare…
FDA approves new product to treat hereditary angioedema
On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of acute attacks…
Study: Nearly 80% of deaths in first three decades of life traced to unintentional injury or violence
According to a report published in Lancet, nearly 80% of US deaths in first three decades of life are due to unintentional injury or…
Study: Higher Hgb or receiving EPO doesn’t improve neuro outcomes in patients with TBI
In patients with a traumatic brain injury (TBI), the administration of the hormone erythropoietin (EPO) or maintaining a higher hemoglobin (Hgb) concentration through blood…
International home care conference
The Second International Home Care Nurses Organization Conference: Person-centred care in home-based nursing-service models, nursing roles and competencies will be held Sept. 23-26, 2014…
Managing knee osteoarthritis in older adults
A degenerative joint disease, osteoarthritis (OA) is marked by cartilage erosion, osteophyte formation, joint hypertrophy, and subchondral sclerosis. A leading cause of disability in…
FDA approves new drug for serious skin infections
On June 20, the U.S. Food and Drug Administration (FDA) approved Sivextro (tedizolid phosphate) to treat patients with acute bacterial skin and skin structure…
FDA approves new indication for imaging agent
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic imaging agent…
FDA approves Afrezza
On June 27, the U.S. Food and Drug Administration (FDA) approved Afrezza (insulin human) Inhalation Powder, a rapid-acting inhaled insulin to improve…
Bullying toolkit available
Access “Civility Tool-kit: Resources to Empower Nurse Leaders to Identify, Intervene, and Prevent Workplace Bullying,” supported by the RWJF Executive Nurse Fellows…
Study: Fecal microbiota transplant effective in immunocompromised patients
Fecal microbiota transplant (FMT) for the treatment of Clostridium difficile infection in immunocompromised patients is safe and effective, according to a study…
Lessons for more efficient research in healthcare settings
My Own Health Report, a collaboration between seven research institutions with the goal of streamlining how healthcare providers communicate with patients about…
FDA approves drug for treating rare type of non-Hodgkin lymphoma
On July 3, the U.S. Food and Drug Administration (FDA) approved Beleodaq (belinostat) for the treatment of patients with peripheral T-cell lymphoma,…
FDA approves new product to treat hereditary angioedema
On July 16, the U.S. Food and Drug Administration (FDA) approved Ruconest, the first recombinant C1-Esterase Inhibitor product for the treatment of…
Study: Nearly 80% of deaths in first three decades of life traced to unintentional injury or violence
According to a report published in Lancet, nearly 80% of US deaths in first three decades of life are due to unintentional…
Study: Higher Hgb or receiving EPO doesn’t improve neuro outcomes in patients with TBI
In patients with a traumatic brain injury (TBI), the administration of the hormone erythropoietin (EPO) or maintaining a higher hemoglobin (Hgb) concentration…
International home care conference
The Second International Home Care Nurses Organization Conference: Person-centred care in home-based nursing-service models, nursing roles and competencies will be held Sept.…
Managing knee osteoarthritis in older adults
A degenerative joint disease, osteoarthritis (OA) is marked by cartilage erosion, osteophyte formation, joint hypertrophy, and subchondral sclerosis. A leading cause of…
FDA approves new drug for serious skin infections
On June 20, the U.S. Food and Drug Administration (FDA) approved Sivextro (tedizolid phosphate) to treat patients with acute bacterial skin and…
FDA approves new indication for imaging agent
On June 13, the U.S. Food and Drug Administration (FDA) a new use for Lymphoseek (technetium 99m tilmanocept) Injection, a radioactive diagnostic…
Poll
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.